Clinical Trials Browser

Brain Neoplasms × Sunitinib × Sarcoma × Clear all

NCT03641326 2022-04-19

Sunitinib in Sarcomas of the Central Nervous System

Phase 2 Terminated

5 enrolled 14 charts

Brain Neoplasms, Gliosarcoma